Actively Recruiting

Phase Not Applicable
Age: 6Years +
All Genders
NCT07085065

Distraction With Virtual Reality From Pain and Anxiety for Patients With Hematological Malignancies

Led by Yesmine Amara · Updated on 2025-07-25

365

Participants Needed

1

Research Sites

78 weeks

Total Duration

On this page

Sponsors

Y

Yesmine Amara

Lead Sponsor

U

University of Sfax

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial\] is to study the effectiveness of Virtual Reality (VR) in reducing pain and anxiety during painful procedures for patients with hematological malignancies The main question\[s\] it aims to answer are: Does VR effectively reduce pain during painful procedures for patients with hematological malignancies ? Does VR effectively reduce anxiety during painful procedures for patients with hematological malignancies ? Interventional group (intra-group comparaison): This design allows each patient to act as his own control.: The intervention consists of a complete sequence involving three phases: Period 1 (standard care), a washout period of at least seven days, and Period 2 (VR session). External control group (inter-group comparaison): Patients will be assigned to the intervention group first, and then a matching external control patient will be selected based on age and type of procedure.

CONDITIONS

Official Title

Distraction With Virtual Reality From Pain and Anxiety for Patients With Hematological Malignancies

Who Can Participate

Age: 6Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Being 6 years old or older
  • Having a confirmed diagnosis of a hematological malignancy
  • Undergoing at least one of the following procedures: Bone Marrow Biopsy, Bone Marrow Aspiration, Lumbar Puncture, Venipuncture, or Chemotherapy
Not Eligible

You will not qualify if you...

  • Unstable or photosensitive epilepsy
  • Hearing, visual, or inner ear impairments
  • Severe psychiatric, cognitive, or mental disorders
  • Contagious diseases
  • Communication difficulties
  • Patients who withdraw consent
  • Patients who remove the VR headset during the procedure

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Clinical hematology department of unversity hospital of Hedi Chaker of Sfax, Tunisia

Tunis, Sfax Governorate, Tunisia, 3002

Actively Recruiting

Loading map...

Research Team

Y

Yesmine Amara, PhD student

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

NON_RANDOMIZED

Model

CROSSOVER

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here